| Systematic review of peer-support programs for people with cancer LM Hoey, SC Ieropoli, VM White, M Jefford Patient education and counseling 70 (3), 315-337, 2008 | 511 | 2008 |
| Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets T Luft, M Jefford, P Luetjens, T Toy, H Hochrein, KA Masterman, ... Blood, The Journal of the American Society of Hematology 100 (4), 1362-1372, 2002 | 483 | 2002 |
| Improvement of informed consent and the quality of consent documents M Jefford, R Moore The lancet oncology 9 (5), 485-493, 2008 | 428 | 2008 |
| Informing and involving cancer patients in their own care M Jefford, MHN Tattersall The lancet oncology 3 (10), 629-637, 2002 | 348 | 2002 |
| Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review K Lotfi-Jam, M Carey, M Jefford, P Schofield, C Charleson, S Aranda Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2008 | 221 | 2008 |
| Survivorship issues following treatment completion—results from focus groups with Australian cancer survivors and health professionals M Jefford, E Karahalios, A Pollard, C Baravelli, M Carey, J Franklin, ... Journal of Cancer Survivorship 2, 20-32, 2008 | 206 | 2008 |
| Rational approaches to human cancer immunotherapy ID Davis, M Jefford, P Parente, J Cebon Journal of Leucocyte Biology 73 (1), 3-29, 2003 | 200 | 2003 |
| Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA M Jefford, J Rowland, E Grunfeld, M Richards, J Maher, A Glaser British journal of cancer 108 (1), 14-20, 2013 | 177 | 2013 |
| Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians P Schofield, J Diggens, C Charleson, R Marigliani, M Jefford Patient education and counseling 79 (2), 143-151, 2010 | 168 | 2010 |
| Importance of health literacy in oncology K Koay, P Schofield, M Jefford Asia‐Pacific Journal of Clinical Oncology 8 (1), 14-23, 2012 | 165 | 2012 |
| Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial MR Stockler, R O'Connell, AK Nowak, D Goldstein, J Turner, ... The lancet oncology 8 (7), 603-612, 2007 | 165 | 2007 |
| IL-1β enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation T Luft, M Jefford, P Luetjens, H Hochrein, KA Masterman, C Maliszewski, ... The Journal of Immunology 168 (2), 713-722, 2002 | 160 | 2002 |
| Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? SJ Breen, CM Baravelli, PE Schofield, M Jefford, PM Yates, SK Aranda Medical Journal of Australia 190, S99-S104, 2009 | 158 | 2009 |
| Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli M Jefford, M Schnurr, T Toy, KA Masterman, A Shin, T Beecroft, TY Tai, ... Blood 102 (5), 1753-1763, 2003 | 156 | 2003 |
| Impact of a novel nurse-led prechemotherapy education intervention (ChemoEd) on patient distress, symptom burden, and treatment-related information and support needs: results … S Aranda, M Jefford, P Yates, K Gough, J Seymour, P Francis, C Baravelli, ... Annals of oncology 23 (1), 222-231, 2012 | 149 | 2012 |
| Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild … LL Siu, JD Shapiro, DJ Jonker, CS Karapetis, JR Zalcberg, J Simes, ... J Clin Oncol 31 (19), 2477-2484, 2013 | 146* | 2013 |
| The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand M Shackleton, ID Davis, W Hopkins, H Jackson, N Dimopoulos, T Tai, ... Cancer Immunity 4 (1), 2004 | 143 | 2004 |
| Management of cancer and health after the clinic visit: a call to action for self-management in cancer care D Howell, DK Mayer, R Fielding, M Eicher, IM Verdonck-de Leeuw, ... Jnci: journal of the national cancer institute 113 (5), 523-531, 2021 | 140 | 2021 |
| Identifying the most prevalent unmet needs of cancer survivors in Australia: A systematic review K Lisy, L Langdon, A Piper, M Jefford Asia‐Pacific Journal of Clinical Oncology 15 (5), e68-e78, 2019 | 140 | 2019 |
| The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up C Baravelli, M Krishnasamy, C Pezaro, P Schofield, K Lotfi-Jam, ... Journal of Cancer Survivorship 3, 99-108, 2009 | 137 | 2009 |
